Your account is not claimed yet. You can sign up with ORCID to claim your account.

Vladimir Makarov

Publication Activity (10 Years)

Years Active: 2017-2020
Publications (10 Years): 3

Top Topics

Genetic Diversity

Induced Pluripotent Stem Cells

Advanced Cancer

Top Venues

Science (New York, N.Y.)

Science immunology

Sloan Kettering Institute

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Sloan Kettering Institute Apr 10o 2000

United States

Bioinfo.Engr.III :: Chan lab

Publications

Simon Heidegger, Alexander Wintges, Florian Stritzke, Sarah Bek, Katja Steiger, Paul-Albert Koenig, Sascha Göttert, Thomas Engleitner, Rupert Öllinger, Tatiana Nedelko, Julius Clemens Fischer, Vladimir Makarov, Christof Winter, Roland Rad, Marcel R M van den Brink, Juergen Ruland, Florian Bassermann, Timothy A Chan, Tobias Haas, Hendrik Poeck
RIG-I activation is critical for responsiveness to checkpoint blockade. Science immunology 4 (39) (2020)
Rajarsi Mandal, Robert M Samstein, Ken-Wing Lee, Jonathan J Havel, Hao Wang, Chirag Krishna, Erich Y Sabio, Vladimir Makarov, Fengshen Kuo, Pedro Blecua, Apoorva T Ramaswamy, Jennifer N Durham, Bjarne Bartlett, Xiaoxiao Ma, Raghvendra Srivastava, Sumit Middha, Ahmet Zehir, Jaclyn F Hechtman, Luc G T Morris, Nils Weinhold, Nadeem Riaz, Dung T Le, Luis A Diaz, Timothy A Chan
Genetic diversity of tumors with mismatch repair deficiency influences anti-PD-1 immunotherapy response. Science (New York, N.Y.) 364 (6439) (2019)
Diego Chowell, Luc G T Morris, Claud M Grigg, Jeffrey K Weber, Robert M Samstein, Vladimir Makarov, Fengshen Kuo, Sviatoslav M Kendall, David Requena, Nadeem Riaz, Benjamin Greenbaum, James Carroll, Edward Garon, David M Hyman, Ahmet Zehir, David B Solit, Michael F Berger, Ruhong Zhou, Naiyer A Rizvi, Timothy A Chan
Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy. Science (New York, N.Y.) 359 (6375) (2017)